Catella APAM has completed a full-floor letting at Arlington Park, Reading – following a series of recent leasing successes that underline the Park’s appeal to ambitious, growth-oriented occupiers.
Ridge and Partners LLP (“Ridge”), a built environment consultancy, which has committed to the remaining 9,058 sq ft for 10 years. The deal reflects the strength of Arlington Park’s scalable workspace offer and its appeal to a diverse range of growth-focused businesses.
Commenting on the move, Adrian Goulding, Partner at Ridge, said: “When relocating, location was obviously a key consideration but the quality of the space and environment for our staff was critical. Arlington Park provides great office space in a wider surrounding that has been a pleasure to become part of. The park management team do a great job in maintaining the lake and the landscaping which together with the café and gym provides an amazing environment for staff to enjoy.”
Joining Ridge on the same floor is Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system disorders. Neuraxpharm has signed a new five-year lease for 2,250 sq ft on the first floor of Building 1410.
A short-term extension will allow Neuraxpharm to remain in their existing space until December 2025 while transitioning into their new headquarters – which has been delivered with a Cat B landlord fit-out to support a seamless move.
“This letting highlights our ability to support occupiers from day one through to full-scale expansion,” said Max Bingham, Asset Manager at Catella APAM. “It’s a great endorsement of the Park’s flexibility, connectivity, and amenity provision.”
With sustained activity across both flex and traditional leasing, Arlington Park continues to attract ambitious, growth-oriented companies in a well-connected and amenity-rich environment.